Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models.
Saved in:
| Title: | Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models. |
|---|---|
| Authors: | Gruber DR; Pfizer, Inc., Bothell, Washington., Cummins EJ; Pfizer, Inc., Bothell, Washington., Zeng W; Pfizer, Inc., Bothell, Washington., Ulrich M; Pfizer, Inc., Bothell, Washington., Smith K; Pfizer, Inc., Bothell, Washington., Long M; Pfizer, Inc., Bothell, Washington., Spahr K; Pfizer, Inc., Bothell, Washington., Higgins S; Pfizer, Inc., Bothell, Washington., Hinricher K; Pfizer, Inc., Bothell, Washington., Langalia A; Pfizer, Inc., Bothell, Washington., Krumm K; Pfizer, Inc., Bothell, Washington., Olson DJ; Pfizer, Inc., Bothell, Washington., Grogan B; Pfizer, Inc., Bothell, Washington., Mazahreh R; Pfizer, Inc., Bothell, Washington., Gupta P; Pfizer, Inc., Bothell, Washington., Burke PJ; Pfizer, Inc., Bothell, Washington., Smith A; Pfizer, Inc., Bothell, Washington., Senter PD; Pfizer, Inc., Bothell, Washington., Gardai SJ; Pfizer, Inc., Bothell, Washington., Hill AG; Pfizer, Inc., Bothell, Washington., Gray EE; Pfizer, Inc., Bothell, Washington. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 02; Vol. 25 (3), pp. 457-468. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
